Avalere Health Inc.

Avalere Health Inc. specializes in healthcare consulting and advisory services, focusing on enhancing patient access and navigating complex industry challenges for life sciences, health plans, and private equity firms. Founded in 2000 by Jennifer Mendelson, Avalere Health Inc. operates from its headquarters in Washington, US.

The company has completed a total of 3 deals, with its most recent being a TRADE SALE to Inovalon Holdings, Inc. on August 24, 2015, for USD 140. 00 mn. There are no indications of significant changes in business strategy or operations since its inception.

Avalere Health provides a comprehensive suite of consulting and advisory services tailored to the healthcare sector, focusing on enhancing patient access and navigating complex industry challenges. Their main offerings include due diligence, market access strategies, implementation science, and federal and state policy analysis. These services are designed to support life sciences companies, health plans, providers, and private equity firms, enabling them to strategically position themselves in the market and optimize their operations. Avalere Health partners with clients to create actionable strategies supported by data-driven insights, ultimately aiming to ensure that no patient is left behind.

The company serves a diverse client base across various geographical markets, including North America and Europe, addressing the health needs and regulatory landscapes specific to these regions. Avalere Health's revenue model is primarily based on B2B consulting arrangements, where clients engage the firm for tailored advisory services in healthcare strategy and analysis. Transactions typically occur through project-based contracts or ongoing partnerships, with clients including pharmaceutical manufacturers, healthcare providers, and private equity firms seeking to leverage Avalere's expertise. The structure of these transactions often involves fixed fees or retainer agreements for specific services, with pricing reflective of the customized nature of the solutions provided.

While specific pricing details are not publicly disclosed, flagship services such as market access consulting and implementation science are integral to the firm’s offerings, contributing to their overall revenue generation strategy. The firm’s strong market presence and reputation for delivering impactful insights underpin its business transactions in the healthcare consulting landscape. Following its acquisition by Inovalon Inc. in August 2015, Avalere Health plans to leverage its enhanced resources to expand its service offerings.

The integration aims to facilitate the development of new products addressing emerging healthcare challenges, although specific launch dates are yet to be disclosed. The company aims to penetrate further into European markets by 2025, aligning its strategies with local regulatory frameworks and market needs. The recent TRADE SALE transaction valued at USD 140. 00 mn is expected to support these initiatives, enabling investment in technology and talent necessary for expanding its advisory capabilities.